Abstract Topics

 Abstract Submission is Opened!

Wednesday, March 19, 2025

Abstract Submission Guidelines

Basic Science

  • Taxonomy
  • Animal Models and Papillomaviruses
  • Immunology
  • Regulation of Gene Expression, Post-transcriptional Modification
  • Transformation and Carcinogenesis
  • Structural Biology
  • Virus – Host Interactions
  • Virus Life Cycle
  • Genomics of HPV-Associated Disease
  • Papillomavirus Vaccines: Basic Science aspects
  • Beta and Gamma Cutaneous HPV Infection, Biology, and Natural History
  • Microbiome

Clinical Science

  • Cervical precancers and cancers: Diagnosis, Decision making and follow up
  • Anal HPV associated precancers and cancers: Diagnosis, decision making and follow up
  • HPV associated anogenital cancers other than cervix (penile, vaginal, vulvar precancers and cancers): Diagnosis, decision making and follow up
  • Treatment of cervical, anal, vulvar, and penilel pre-cancer and cancer
  • HPV associated Oral cancers and precancers: Diagnosois, Management and treatment
  • Diagnosis and management of HPV disease in special populations (immunosuppressed, PLHIV, gender and non-binary communities, children, history of sexual abuse)
  • Screening, Diagnosis and Treatment of cervical Precancer in Low-resource Settings
  • Innovation for in sample collection for HPV related screening.
  • Novel biomarkers for diagnosis, management and post treatment follow up for cervical precancers and cancers
  • Novel biomarkers for diagnosis, management and post treatment follow up for anal precancers and cancers
  • Novel biomarkers for diagnosis, management and post treatment follow up for oral precancers and cancers
  • Novel biomarkers for diagnosis, management and post treatment follow up for other HPV associated precancers and cancers (penile, vulvar, vaginal)
  • Novel excisional/ablative treatments for HPV associated disease
  • Emerging Therapeutic Vaccines and antivirals for HPV associated disease – Clinical Aspects (development, efficacy and safety)
  • Prophylactic Vaccines (clinical trial data, safety and efficacy)
  • Rapid assays for the detection of HPV-Related Disease
  • HPV NAAT screening quality control/assurance guidelines
  • AI technology for diagnosis and management in HPV-associated disease
  • Recurrent Respiratory Papillomatosis (clinical aspects including diagnosis, clinical management)
  • Vertical HPV transmission and obstetrical complications of cervical HPV infection and treatment of cervical precancer
  • Psyco-social elements and cultural factors impacting HPV associated testing, diagnosis, management and treatment of women with HPV associated diseases

Public Health, Epidemiology and Implementation Science

  • Cervical screening: Public health program and implementation aspects
  • Prevention (primary and secondary) of HPV-related anal cancer
  • Prevention (primary and secondary) of HPV-related oropharyngeal cancer
  • HPV vaccination: Effectiveness and impact
  • HPV vaccination: Public health program and implementation aspects
  • Health economics and mathematical modelling of HPV and HPV-related conditions
  • AI and machine learning in HPV-related population health research
  • Country/region specific reports of HPV vaccine and screening coverage
  • Behavioral science and communications research related to HPV prevention (primary and secondary)
  • Recurrent Respiratory Papillomatosis: epidemiology and prevention
  • Implementation Science related to HPV infection and related disease prevention
  • Primary results for clinical trials
  • Other topics related to HPV infection and related disease prevention
Subscribe Visit 2024 website IPVS Education Center Membership